Newmark Group
NMRK
9.70
-0.06
-0.61%
Newmark Group
US · NMRK
#2694 by market cap
Listed 2017
9.70
-0.06
-0.61%
Periodic snapshot; not a real-time feed.
· 2026-11-20 17:26
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.52, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +20.29% YoY
Margins
- Operating margin
- 7.10%
- Net margin
- 3.83%
Key ratios & quality
- Enterprise valuei
- 3.18B
- PEG ratioi
- 0.81
- Altman Z-Scorei
- 1.52
PEG uses trailing P/E against the 3-year net income growth rate (14.86%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.05B | 2.22B | 1.90B | 2.91B | 2.71B | 2.47B | 2.74B | 3.29B |
| Gross profit | -- | -- | -- | -- | -- | -- | -- | -- |
| Selling & admin expenses | 1.39B | 1.53B | 1.28B | 2.19B | 1.69B | 1.63B | 1.78B | 2.23B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 332.59M | 246.24M | 184.00M | 1.25B | 185.57M | 125.22M | 163.04M | 234.00M |
| Pretax profit | 282.39M | 214.15M | 146.27M | 1.22B | 154.60M | 103.48M | 131.27M | 201.52M |
| Tax | 90.49M | 52.44M | 36.99M | 242.96M | 42.05M | 41.10M | 45.78M | 46.07M |
| Net profit | 191.90M | 161.71M | 109.28M | 978.13M | 112.55M | 62.38M | 85.49M | 155.45M |
| Basic EPS | 1 | 1 | 0 | 4 | 0 | 0 | 0 | 1 |
| Diluted EPS | 0.64 | 0.58 | 0.39 | 3.80 | 0.45 | 0.24 | 0.34 | 0.68 |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Revenue | 759.11M | 863.46M | 1.01B | 846.52M | 888.42M | 973.20M |
| Gross profit | -- | -- | -- | -- | -- | -- |
| Selling & admin expenses | 515.18M | 591.34M | 649.14M | 584.00M | 607.82M | 636.54M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 42.74M | 85.16M | 123.62M | 26.96M | 40.41M | 85.18M |
| Pretax profit | 33.72M | 77.19M | 116.62M | 20.05M | 33.00M | 76.96M |
| Tax | 4.21M | 18.73M | 33.19M | 3.43M | 9.58M | 17.97M |
| Net profit | 29.51M | 58.45M | 83.43M | 16.62M | 23.42M | 58.99M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.11 | 0.25 | 0.37 | 0.08 | 0.11 | 0.27 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.76B | 1.07B | 1.82B | 2.52B | 1.08B | 1.51B | 1.77B | 2.01B |
| Cash & ST investments | 171.42M | 200.36M | 224.73M | 715.90M | 233.80M | 164.89M | 197.69M | 229.11M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 3.45B | 3.20B | 3.98B | 5.22B | 3.94B | 4.47B | 4.71B | 5.02B |
| Total current liabilities | 1.66B | 1.05B | 1.71B | 2.19B | 1.58B | 1.49B | 1.78B | 1.91B |
| Short-term debt | 972.39M | 273.57M | 1.12B | 1.27B | 782.05M | 605.72M | 862.74M | 993.82M |
| Long-term debt | 537.93M | 589.29M | 680.39M | 545.24M | -- | 547.26M | 670.67M | 671.75M |
| Total liabilities | 2,397,358,000.00 | 2,260,974,000.00 | 3,061,303,000.00 | 3,552,008,000.00 | 2,415,894,000.00 | 2,892,893,000.00 | 3,185,951,000.00 | 3,279,412,000.00 |
| Total equity | 1.06B | 940.63M | 921.15M | 1.66B | 1.52B | 1.58B | 1.52B | 1.74B |
| Retained earnings | 277.95M | 313.11M | 342.76M | 1.08B | 1.15B | 1.17B | 1.21B | 1.31B |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Total current assets | 2.34B | 2.44B | 2.01B | 2.27B | 2.10B | 2.64B |
| Cash & ST investments | 195.83M | 224.09M | 229.11M | 212.07M | 259.70M | 274.63M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 5.39B | 5.46B | 5.02B | 5.28B | 5.19B | 5.76B |
| Total current liabilities | 2.26B | 2.37B | 1.91B | 2.10B | 1.92B | 2.42B |
| Short-term debt | 1.40B | 1.45B | 993.82M | 1.22B | 1.01B | 1.40B |
| Long-term debt | 871.21M | 746.48M | 671.75M | 832.02M | 867.28M | 877.51M |
| Total liabilities | 3,876,504,000.00 | 3,840,571,000.00 | 3,279,412,000.00 | 3,598,487,000.00 | 3,449,367,000.00 | 3,994,233,000.00 |
| Total equity | 1.51B | 1.62B | 1.74B | 1.68B | 1.74B | 1.77B |
| Retained earnings | 1.21B | 1.25B | 1.31B | 1.32B | 1.33B | 1.37B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -332.37M | 986.76M | -777.69M | -48.71M | 1.20B | -265.96M | -9.94M | 172.00M |
| Depreciation & amortization | 97.73M | 131.14M | 141.19M | 121.73M | 165.82M | 166.22M | 174.30M | 181.30M |
| Free cash flow | -356.49M | 950.75M | -797.52M | -68.43M | 1.13B | -321.32M | -42.95M | 142.63M |
| Dividends paid | -41.79M | -69.25M | -23.17M | -7.63M | -17.93M | -20.91M | -20.62M | -21.72M |
| Stock buybacks / issuance | -486.00K | -37.37M | -6.36M | -290.54M | -294.80M | -37.43M | -212.57M | -127.07M |
| Ending cash balance | 187.41M | 221.87M | 258.40M | 266.50M | 312.95M | 258.71M | 304.87M | 233.91M |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Operating cash flow | -379.74M | 112.63M | 618.52M | -247.60M | 362.47M | -290.29M |
| Depreciation & amortization | 42.61M | 45.46M | 46.87M | 46.23M | 45.98M | 45.07M |
| Free cash flow | -386.24M | 104.90M | 608.82M | -257.81M | 341.68M | -306.50M |
| Dividends paid | -5.55M | -5.33M | -5.43M | -5.44M | -10.71M | -10.91M |
| Stock buybacks / issuance | -125.52M | 0 | -1.55M | -136.35M | -14.80M | -59.38M |
| Ending cash balance | 309.59M | 227.04M | 233.91M | 219.61M | 263.62M | 241.82M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 24.55 | 17.89 | 11.20 | 77.03 | 6.77 | 3.50 | 4.98 | 9.46 |
| ROA %i | 3.55 | 3.14 | 1.96 | 16.19 | 1.82 | 1.01 | 1.33 | 2.59 |
| ROIC %i | 7.06 | 5.58 | 4.54 | 24.26 | 3.37 | 1.99 | 2.63 | 4.45 |
| 5-year avg ROE %i | -- | 16.85 | 19.16 | 30.79 | 27.49 | 23.28 | 20.70 | 20.35 |
| EBIT margin %i | 16.64 | 11.10 | 9.66 | 43.17 | 6.86 | 5.07 | 5.95 | 7.10 |
| FCF / sales %i | -- | 42.86 | -- | -- | 41.92 | -- | -- | 4.33 |
| Current ratioi | 1.06 | 1.03 | 1.07 | 1.15 | 0.68 | 1.01 | 1.00 | 1.05 |
| Quick ratioi | 0.39 | 0.70 | 0.36 | 0.60 | 0.49 | 0.54 | 0.45 | 0.45 |
| Debt / assetsi | 43.72 | 34.07 | 50.80 | 46.09 | 35.76 | 39.16 | 42.96 | 41.89 |
| LT debt / equityi | 94.78 | 136.28 | 137.24 | 88.53 | 53.08 | 91.41 | 96.27 | 75.87 |
| Interest coveragei | 5.84 | -- | 4.88 | 37.48 | 5.99 | 5.76 | 5.13 | 7.20 |
| Revenue CAGR (3Y) %i | 19.49 | 18.00 | 6.07 | 12.38 | 6.85 | 9.05 | -1.96 | 6.78 |
| Net income CAGR (3Y) %i | -- | -11.35 | -17.87 | 91.60 | -10.79 | -18.98 | -56.63 | 14.86 |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | 6.06 | -- | -- | -49.90 |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| ROE %i | 6.06 | 8.16 | 9.46 | 10.98 | 10.91 | 10.68 |
| ROA %i | 1.48 | 1.98 | 2.59 | 2.95 | 2.80 | 2.69 |
| ROIC %i | 2.71 | 3.40 | 4.45 | 4.68 | 4.39 | 4.22 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 5.70 | 6.78 | 7.10 | 8.01 | 7.66 | 7.44 |
| FCF / sales %i | -- | -- | 4.33 | 2.00 | 22.13 | 10.40 |
| Current ratioi | 1.04 | 1.03 | 1.05 | 1.08 | 1.09 | 1.09 |
| Quick ratioi | 0.35 | 0.35 | 0.45 | 0.42 | 0.48 | 0.42 |
| Debt / assetsi | 51.07 | 48.71 | 41.89 | 46.63 | 43.77 | 47.02 |
| LT debt / equityi | 105.92 | 88.16 | 75.87 | 88.54 | 88.04 | 89.28 |
| Interest coveragei | 5.03 | 6.32 | 7.20 | 9.01 | 9.42 | 9.35 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Real estate services100.00%
Quote time 2026-11-20 17:26:41 · For reference only, not investment advice and not tailored to your situation.
Newmark Group discussion 0 comments